Follow The Filings

HROW Harrow

Harrow earnings company data as of 4:47 AM ET 10/22

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS 0.16 — —
Rev — — —

Insider trades

Open-market buys and sales by HROW's executives, directors and 10% owners in the last 12 months, from their Form 4s

All HROW insider trades
  • $469K bought by 4 insiders
  • $9.6M sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Amir Shojaei Chief Scientific Officer
    Sale
    $450K 11,250 shares at $40.00 100% of stake
    Traded Aug 14 Filed Aug 17
  2. Adrienne L Graves Director
    Buy
    $31K 1,000 shares at $31.07 New stake
    Traded May 18 Filed May 19
  3. Lauren P Silvernail Director
    Buy
    $31K 1,000 shares at $31.00 New stake
    Traded May 18 Filed May 19
  4. Mark L Baum CEO
    Buy
    $302K 10,000 shares at $30.20 +0.3% to stake
    Traded May 14 Filed May 15
  5. Andrew R. Boll CFO
    Buy
    $105K 3,500 shares at $29.90 +0.4% to stake
    Traded May 14 Filed May 15
  6. Opaleye Management Inc. 10% owner
    Sale
    $7.8M 198,572 shares at $39.51 77% of stake
    Traded Mar 3–4 Filed Mar 5
  7. Opaleye Management Inc. 10% owner
    Sale
    $271K 5,000 shares at $54.18 7.1% of stake
    Traded Feb 27 Filed Mar 3
  8. Opaleye Management Inc. 10% owner
    Sale
    $1.1M 20,000 shares at $53.35 22% of stake
    Traded Jan 6 Filed Jan 8

Also filed in the last 12 months, not counted as buying or selling: 3 option exercises and 2 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 1.01,2.01,7.01,9.01
8-K 5.02,9.01
8-K 2.02,7.01,9.01
10-Q
8-K 1.01,7.01,9.01
SCHEDULE 13G/A —
8-K 5.07
8-K 7.01,9.01
SCHEDULE 13G/A —
8-K 2.02,7.01,9.01
10-Q
DEF 14A
DEFA14A
SCHEDULE 13G/A —
8-K 1.01,2.03,8.01,9.01
8-K 8.01,9.01
8-K 8.01,9.01
SCHEDULE 13G —
8-K 7.01,9.01
8-K 2.02,7.01,9.01
10-K
8-K 2.02,5.02,9.01
8-K 2.01,3.02,8.01,9.01
8-K 2.02,7.01,9.01
10-Q

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.